1. In Vivo

In Europe, A Device Incubator Takes On New Partners

MD Start, a European medical device incubator, was launched in 2009 as a collaboration between medtech giant Medtronic Inc. and Paris-based venture firm Sofinnova Partners, to help European physicians bring their ideas to market. The incubator announces two new shareholders in the venture, reinforcing both its US and European connections: Milan-based cardiovascular leader Sorin Group SPA and US venture firm Versant Ventures.

MD Start, a European medical device incubator launched in 2009 as a collaboration between medtech giant Medtronic PLC and Paris-based venture firm Sofinnova Partners, has announced two new shareholders in the venture, reinforcing both its US and European connections: Milan-based cardiovascular leader Sorin Group SPA and US venture firm Versant Ventures. ( See "In Europe, Medtronic and Sofinnova Launch An Accelerator," IN VIVO, December 2009 Also see "In Europe, Medtronic and Sofinnova Launch an Accelerator" - In Vivo, 1 December, 2009..)

MD Start CEO Tim Lenihan founded the incubator along with Gérard Hascoët in an effort, in particular, to help European...

More from Global Vision

More from In Vivo

Deals In Depth: June 2025

 
• By Deanna Kamienski and Maureen Riordan

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By Jung Won Shin

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By Jo Shorthouse

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.